DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES OF HEALTH 
HUMAN GENE THERAPY SUBCOMMITTEE 
MINUTES OF MEETING^ 
April 5, 1991 
The Human Gene Therapy Subcommittee (HGTS) (a subcommittee of the Recombinant 
DNA Advisory Committee) was convened at 9:00 a.m. on April 5, 1991, in Building 3 1C, 
Conference Room 6, National Institutes of Health, 9000 Rockville Pike, Bethesda, 
Maryland 20892. Dr. LeRoy Walters (Chair) presided. In accordance with Public Law 
92-463, the meeting was open to the public. The following were present for all or part of 
the meeting: 
Committee members: 
Alexander M. Capron, University of Southern California 
James F. Childress, University of Virginia 
Charles J. Epstein, University of California, San Francisco 
Robert P. Erickson, University of Arizona 
Martin F. Gellert, National Institutes of Health 
William N. Kelley, University of Pennsylvania Medical Center 
Brigid G. Leventhal, Johns Hopkins Oncology Center 
R. Scott Mclvor, University of Minnesota 
Abbey S. Meyers, National Organization for Rare Disorders 
Robert F. Murray, Jr., Howard University 
Robertson Parkman, Childrens Hospital of Los Angeles 
LeRoy Walters, Georgetown University 
Executive secretary: 
Nelson A. Wivel, National Institutes of Health 
A committee roster is attached (Attachment). 
Ad hoc consultant: 
Robert M. Cook-Deegan, Biomedical Ethics Advisory Conunittee 
^The Human Gene Therapy Subcommittee is advisory to the Recombinant DNA 
Advisory Committee, and its recommendations should not be considered as final 
or accepted. The Office of Recombinant DNA Activities should be consulted for 
NIH policy on specific issues. 
Recombinant DNA Research, Volume 14 
[559] 
